Barbro Ehlin‐Henriksson

2.1k total citations
43 papers, 1.8k citations indexed

About

Barbro Ehlin‐Henriksson is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Barbro Ehlin‐Henriksson has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 26 papers in Pathology and Forensic Medicine and 22 papers in Immunology. Recurrent topics in Barbro Ehlin‐Henriksson's work include Viral-associated cancers and disorders (31 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immune Cell Function and Interaction (15 papers). Barbro Ehlin‐Henriksson is often cited by papers focused on Viral-associated cancers and disorders (31 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immune Cell Function and Interaction (15 papers). Barbro Ehlin‐Henriksson collaborates with scholars based in Sweden, United States and United Kingdom. Barbro Ehlin‐Henriksson's co-authors include George Klein, Pierre Åman, Joakim Dillner, Bengt Kallin, Ingemar Ernberg, Raymond Frade, Monique Barel, Peter Perlmann, Hannu Koho and Staffan Paulie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Barbro Ehlin‐Henriksson

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbro Ehlin‐Henriksson Sweden 25 1.1k 839 569 418 334 43 1.8k
R J Murray United Kingdom 12 1.1k 1.0× 776 0.9× 522 0.9× 508 1.2× 311 0.9× 14 1.5k
S. Finerty United Kingdom 22 948 0.9× 361 0.4× 473 0.8× 460 1.1× 358 1.1× 36 1.3k
Toyoro Õsato Japan 23 2.0k 1.9× 740 0.9× 1.2k 2.1× 583 1.4× 543 1.6× 100 2.7k
Noémi Nagy Sweden 24 867 0.8× 787 0.9× 451 0.8× 285 0.7× 189 0.6× 71 1.8k
Claire Shannon‐Lowe United Kingdom 27 1.7k 1.5× 830 1.0× 791 1.4× 696 1.7× 272 0.8× 36 2.3k
E Tatsumi Japan 21 612 0.6× 685 0.8× 506 0.9× 129 0.3× 126 0.4× 82 1.8k
G Lenoir France 19 655 0.6× 380 0.5× 474 0.8× 200 0.5× 188 0.6× 42 1.3k
J M Zarling United States 16 549 0.5× 791 0.9× 192 0.3× 467 1.1× 129 0.4× 20 1.7k
Heather M. Long United Kingdom 24 1.2k 1.1× 902 1.1× 553 1.0× 596 1.4× 270 0.8× 37 1.8k
Nikolaus Müller‐Lantzsch Germany 16 838 0.8× 268 0.3× 614 1.1× 209 0.5× 219 0.7× 25 1.4k

Countries citing papers authored by Barbro Ehlin‐Henriksson

Since Specialization
Citations

This map shows the geographic impact of Barbro Ehlin‐Henriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbro Ehlin‐Henriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbro Ehlin‐Henriksson more than expected).

Fields of papers citing papers by Barbro Ehlin‐Henriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbro Ehlin‐Henriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbro Ehlin‐Henriksson. The network helps show where Barbro Ehlin‐Henriksson may publish in the future.

Co-authorship network of co-authors of Barbro Ehlin‐Henriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Barbro Ehlin‐Henriksson. A scholar is included among the top collaborators of Barbro Ehlin‐Henriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbro Ehlin‐Henriksson. Barbro Ehlin‐Henriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Liang, Barbro Ehlin‐Henriksson, Hong Zhu, Ingemar Ernberg, & George Klein. (2013). EBV counteracts IL‐21‐induced apoptosis in an EBV‐positive diffuse large B‐cell lymphoma cell line. International Journal of Cancer. 133(3). 766–770. 11 indexed citations
3.
Ehlin‐Henriksson, Barbro, et al.. (2008). Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein–Barr virus infection. Immunology. 127(4). 549–557. 30 indexed citations
4.
Ehlin‐Henriksson, Barbro, et al.. (2006). Epstein–Barr virus infection negatively impacts the CXCR4‐dependent migration of tonsillar B cells. Immunology. 117(3). 379–385. 21 indexed citations
5.
Ehlin‐Henriksson, Barbro, John Gordon, & George Klein. (2003). B‐lymphocyte subpopulations are equally susceptible to Epstein–Barr virus infection, irrespective of immunoglobulin isotype expression. Immunology. 108(4). 427–430. 29 indexed citations
6.
Kashuba, Elena, Karin Mattsson, Katja Pokrovskaja Tamm, et al.. (2003). EBV‐encoded EBNA‐5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF‐expressing cells. International Journal of Cancer. 105(5). 644–653. 23 indexed citations
7.
Tamm, Katja Pokrovskaja, Barbro Ehlin‐Henriksson, Csaba Kiss, et al.. (2002). CD40 ligation downregulates EBNA‐2 and LMP‐1 expression in EBV‐transformed lymphoblastoid cell lines. International Journal of Cancer. 99(5). 705–712. 21 indexed citations
8.
Ehlin‐Henriksson, Barbro, et al.. (1999). Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers. International Journal of Cancer. 83(1). 50–54. 15 indexed citations
9.
Ehlin‐Henriksson, Barbro, et al.. (1993). Correlation between the growth‐inhibitory effect of TGF‐β1 and phenotypic characteristics in a panel of B‐cell lines. International Journal of Cancer. 55(1). 137–140. 10 indexed citations
10.
Lewin, Nongnit, János Minárovits, Günther Weber, et al.. (1991). Clonality and methylation status of the epstein‐barr virus (EBV) genomes in IN V7W‐infected EBV‐carrying chronic lymphocytic leukemia (CLL) cell lines. International Journal of Cancer. 48(1). 62–66. 15 indexed citations
11.
12.
Sakthivel, Ramasamy, Birger Christensson, Barbro Ehlin‐Henriksson, & George Klein. (1989). Immunophenotypic characterization of follicle‐center‐cell‐derived non‐hodgkin's lymphomas. International Journal of Cancer. 43(4). 624–630. 10 indexed citations
13.
Avila‐Cariño, Javier, Sigurbjörg Torsteinsdóttir, Barbro Ehlin‐Henriksson, et al.. (1987). Paired Epstein‐Barr virus (EBV)‐negative and EBV‐converted Burkitt lymphoma lines: Stimulatory capacity in allogeneic mixed lymphocyte cultures. International Journal of Cancer. 40(5). 691–697. 38 indexed citations
14.
Torsteinsdóttir, Sigurbjörg, Maria G. Masucci, Barbro Ehlin‐Henriksson, et al.. (1986). Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.. Proceedings of the National Academy of Sciences. 83(15). 5620–5624. 84 indexed citations
15.
Åman, Pierre, John Gordon, Nongnit Lewin, et al.. (1985). Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.. The Journal of Immunology. 135(4). 2362–2367. 34 indexed citations
16.
Paulie, Staffan, et al.. (1985). A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunology Immunotherapy. 20(1). 23–8. 142 indexed citations
17.
Gordon, John, Pierre Åman, Anders Rosén, et al.. (1985). Capacity of B‐lymphocytic lines of diverse tumor origin to produce and respond to B‐cell growth factors: A progression model for B‐cell lymphomagenesis. International Journal of Cancer. 35(2). 251–256. 50 indexed citations
18.
Åman, Pierre, Barbro Ehlin‐Henriksson, & George Klein. (1984). Epstein-Barr virus susceptibility of normal human B lymphocyte populations.. The Journal of Experimental Medicine. 159(1). 208–220. 160 indexed citations
19.
Szigeti, Robert, Giuseppe Masucci, Barbro Ehlin‐Henriksson, et al.. (1984). EBNA-specific LIF production of human lymphocyte subsets. Cellular Immunology. 83(1). 136–141. 5 indexed citations
20.
Ehlin‐Henriksson, Barbro, Edward A. Clark, Viggo Jønsson, & George Klein. (1983). Studies on the B lymphoblast antigen No. 1 (BB-1) on a series of Burkitt lymphoma lines differing in the expression of the EBV/C3 receptor complex.. The Journal of Immunology. 130(5). 2448–2452. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R J Murray Breakdown of academic impact, for papers by S. Finerty Breakdown of academic impact, for papers by Toyoro Õsato Breakdown of academic impact, for papers by Noémi Nagy Breakdown of academic impact, for papers by Claire Shannon‐Lowe Breakdown of academic impact, for papers by E Tatsumi Breakdown of academic impact, for papers by G Lenoir Breakdown of academic impact, for papers by J M Zarling Breakdown of academic impact, for papers by Heather M. Long Breakdown of academic impact, for papers by Nikolaus Müller‐Lantzsch
Rankless by CCL
2026